-
1
-
-
78149360952
-
Is unrecognized bipolar disorder a frequent contributor to apparent treatment resistant depression?
-
Correa R, Akiskal H, Gilmer W, et al. Is unrecognized bipolar disorder a frequent contributor to apparent treatment resistant depression? J Affect Disord 2010;127:10-18.
-
(2010)
J Affect Disord
, vol.127
, pp. 10-18
-
-
Correa, R.1
Akiskal, H.2
Gilmer, W.3
-
2
-
-
10744220918
-
Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression
-
DOI 10.1001/archpsyc.60.11.1079
-
Tohen M, Vieta E, Calabrese J, et al. Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression. Arch Gen Psychiatry 2003;60:1079-88. (Pubitemid 37429647)
-
(2003)
Archives of General Psychiatry
, vol.60
, Issue.11
, pp. 1079-1088
-
-
Tohen, M.1
Vieta, E.2
Calabrese, J.3
Ketter, T.A.4
Sachs, G.5
Bowden, C.6
Mitchell, P.B.7
Centorrino, F.8
Risser, R.9
Baker, R.W.10
Evans, A.R.11
Beymer, K.12
Dube, S.13
Tollefson, G.D.14
Breier, A.15
-
3
-
-
33645005906
-
Treatment-resistant bipolar depression: A STEP-BD equipoise randomized effectiveness trial of antidepressant augmentation with lamotrigine, inositol, or risperidone
-
DOI 10.1176/appi.ajp.163.2.210
-
Nierenberg AA, Ostacher MJ, Calabrese JR, et al. Treatmentresistant bipolar depression: a STEP-BD equipoise randomized effectiveness trial of antidepressant augmentation with lamotrigine, inositol, or risperidone. Am J Psychiatry 2006;163:210-16. (Pubitemid 44480839)
-
(2006)
American Journal of Psychiatry
, vol.163
, Issue.2
, pp. 210-216
-
-
Nierenberg, A.A.1
Ostacher, M.J.2
Calabrese, J.R.3
Ketter, T.A.4
Marangell, L.B.5
Miklowitz, D.J.6
Miyahara, S.7
Bauer, M.S.8
Thase, M.E.9
Wisniewski, S.R.10
Sachs, G.S.11
-
4
-
-
0034976168
-
Double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depression
-
DOI 10.1176/appi.ajp.158.6.906
-
Nemeroff CB, Evans DL, Gyulai L, et al. Double-blind, placebocontrolled comparison of imipramine and paroxetine in the treatment of bipolar depression. Am J Psychiatry 2001;158:906-12. (Pubitemid 32547620)
-
(2001)
American Journal of Psychiatry
, vol.158
, Issue.6
, pp. 906-912
-
-
Nemeroff, C.B.1
Evans, D.L.2
Gyulai, L.3
Sachs, G.S.4
Bowden, C.L.5
Gergel, I.P.6
Oakes, R.7
Pitts, C.D.8
-
5
-
-
70350136882
-
Revisiting the effectiveness of standard antidepressants in bipolar disorder: Are monoamine oxidase inhibitors superior?
-
Mallinger AG, Frank E, Thase ME, et al. Revisiting the effectiveness of standard antidepressants in bipolar disorder: are monoamine oxidase inhibitors superior? Psychopharmacol Bull 2009;42:64-74.
-
(2009)
Psychopharmacol Bull
, vol.42
, pp. 64-74
-
-
Mallinger, A.G.1
Frank, E.2
Thase, M.E.3
-
6
-
-
0025860380
-
Tranylcypromine versus imipramine in anergic bipolar depression
-
Himmelhoch JM, Thase ME, Mallinger AG, et al. Tranylcypromine versus imipramine in anergic bipolar depression. Am J Psychiatry 1991;148:910-16.
-
(1991)
Am J Psychiatry
, vol.148
, pp. 910-916
-
-
Himmelhoch, J.M.1
Thase, M.E.2
Mallinger, A.G.3
-
7
-
-
0026595036
-
Treatment of imipramineresistant recurrent depression, IV: A double-blind crossover study of tranylcypromine for anergic bipolar depression
-
Thase ME, Mallinger AG, McKnight D, et al. Treatment of imipramineresistant recurrent depression, IV: a double-blind crossover study of tranylcypromine for anergic bipolar depression. Am J Psychiatry 1992;149:195-8.
-
(1992)
Am J Psychiatry
, vol.149
, pp. 195-198
-
-
Thase, M.E.1
Mallinger, A.G.2
McKnight, D.3
-
8
-
-
64549126898
-
Bipolar and major depressive disorder: Neuroimaging the developmental-degenerative divide
-
Savitz J, Drevets WC. Bipolar and major depressive disorder: neuroimaging the developmental-degenerative divide. Neurosci Biobehav Rev 2009;33:699-771.
-
(2009)
Neurosci Biobehav Rev
, vol.33
, pp. 699-771
-
-
Savitz, J.1
Drevets, W.C.2
-
9
-
-
74049093658
-
Imaging phenotypes of major depressive disorder: Genetic correlates
-
Savitz JB, Drevets WC. Imaging phenotypes of major depressive disorder: genetic correlates. Neuroscience 2009;164:300-30.
-
(2009)
Neuroscience
, vol.164
, pp. 300-330
-
-
Savitz, J.B.1
Drevets, W.C.2
-
10
-
-
78650035858
-
Molecular and cellular mechanisms of excitotoxic neuronal death
-
Wang Y, Qin ZH. Molecular and cellular mechanisms of excitotoxic neuronal death. Apoptosis 2010;15:1382-402.
-
(2010)
Apoptosis
, vol.15
, pp. 1382-1402
-
-
Wang, Y.1
Qin, Z.H.2
-
11
-
-
77954993010
-
An update on the role of glutamate in the pathophysiology of depression
-
Mitchell ND, Baker GB. An update on the role of glutamate in the pathophysiology of depression. Acta Psychiatr Scand 2010;122:192-210.
-
(2010)
Acta Psychiatr Scand
, vol.122
, pp. 192-210
-
-
Mitchell, N.D.1
Baker, G.B.2
-
12
-
-
67649238182
-
Remodelling by early-life stress of NMDA receptor-dependent synaptic plasticity in a gene-environment rat model of depression
-
Ryan B, Musazzi L, Mallei A, et al. Remodelling by early-life stress of NMDA receptor-dependent synaptic plasticity in a gene-environment rat model of depression. Int J Neuropsychopharmacol 2009;12:553-9.
-
(2009)
Int J Neuropsychopharmacol
, vol.12
, pp. 553-559
-
-
Ryan, B.1
Musazzi, L.2
Mallei, A.3
-
13
-
-
33746902947
-
Genetic inactivation of the NMDA receptor NR2A subunit has anxiolytic- and antidepressant-like effects in mice
-
DOI 10.1038/sj.npp.1301039, PII 1301039
-
Boyce-Rustay JM, Holmes A. Genetic inactivation of the NMDA receptor NR2A subunit has anxiolytic- and antidepressant-like effects in mice. Neuropsychopharmacology 2006;31:2405-14. (Pubitemid 44607058)
-
(2006)
Neuropsychopharmacology
, vol.31
, Issue.11
, pp. 2405-2414
-
-
Boyce-Rustay, J.M.1
Holmes, A.2
-
14
-
-
67649220685
-
Association analysis of group II metabotropic glutamate receptor genes (GRM2 and GRM3) with mood disorders and fluvoxamine response in a Japanese population
-
Tsunoka T, Kishi T, Ikeda M, et al. Association analysis of group II metabotropic glutamate receptor genes (GRM2 and GRM3) with mood disorders and fluvoxamine response in a Japanese population. Prog Neuropsychopharmacol Biol Psychiatry 2009;33:875-9.
-
(2009)
Prog Neuropsychopharmacol Biol Psychiatry
, vol.33
, pp. 875-879
-
-
Tsunoka, T.1
Kishi, T.2
Ikeda, M.3
-
15
-
-
77955891255
-
A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression
-
Diazgranados N, Ibrahim L, Brutsche NE, et al. A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression. Arch Gen Psychiatry 2010;67:793-802.
-
(2010)
Arch Gen Psychiatry
, vol.67
, pp. 793-802
-
-
Diazgranados, N.1
Ibrahim, L.2
Brutsche, N.E.3
-
16
-
-
1442264398
-
An open-label trial of riluzole in patients with treatment-resistant major depression
-
DOI 10.1176/appi.ajp.161.1.171
-
Zarate CA Jr, Payne JL, Quiroz J, et al. An open-label trial of riluzole in patients with treatment-resistant major depression. Am J Psychiatry 2004;161:171-4. (Pubitemid 38419327)
-
(2004)
American Journal of Psychiatry
, vol.161
, Issue.1
, pp. 171-174
-
-
Zarate Jr., C.A.1
Payne, J.L.2
Quiroz, J.3
Sporn, J.4
Denicoff, K.K.5
Luckenbaugh, D.6
Charney, D.S.7
Manji, H.K.8
-
17
-
-
75849155537
-
A meta-analysis of cytokines in major depression
-
Dowlati Y, Herrmann N, Swardfager W, et al. A meta-analysis of cytokines in major depression. Biol Psychiatry 2010;67:446-57.
-
(2010)
Biol Psychiatry
, vol.67
, pp. 446-457
-
-
Dowlati, Y.1
Herrmann, N.2
Swardfager, W.3
-
18
-
-
70449376943
-
Cytokines and glucocorticoid receptor signaling. Relevance to major depression
-
Pace TW, Miller AH. Cytokines and glucocorticoid receptor signaling. Relevance to major depression. Ann N Y Acad Sci 2009;1179:86-105.
-
(2009)
Ann N y Acad Sci
, vol.1179
, pp. 86-105
-
-
Pace, T.W.1
Miller, A.H.2
-
19
-
-
0026552955
-
Higher alpha 1-antitrypsin, haptoglobin, ceruloplasmin and lower retinol binding protein plasma levels during depression: Further evidence for the existence of an inflammatory response during that illness
-
Maes M, Scharpe S, Van Grootel L, et al. Higher alpha 1-antitrypsin, haptoglobin, ceruloplasmin and lower retinol binding protein plasma levels during depression: further evidence for the existence of an inflammatory response during that illness. J Affect Disord 1992;24:183-92.
-
(1992)
J Affect Disord
, vol.24
, pp. 183-192
-
-
Maes, M.1
Scharpe, S.2
Van Grootel, L.3
-
20
-
-
15744394859
-
Inflammatory markers and sleep disturbance in major depression
-
DOI 10.1097/01.psy.0000149259.72488.09
-
Motivala SJ, Sarfatti A, Olmos L, et al. Inflammatory markers and sleep disturbance in major depression. Psychosom Med 2005;67:187-94. (Pubitemid 40410952)
-
(2005)
Psychosomatic Medicine
, vol.67
, Issue.2
, pp. 187-194
-
-
Motivala, S.J.1
Sarfatti, A.2
Olmos, L.3
Irwin, M.R.4
-
21
-
-
0028258379
-
Changes in immunoglobulin, complement and acute phase protein levels in the depressed patients and normal controls
-
DOI 10.1016/0165-0327(94)90135-X
-
Song C, Dinan T, Leonard BE. Changes in immunoglobulin, complement and acute phase protein levels in the depressed patients and normal controls. J Affect Disord 1994;30:283-8. (Pubitemid 24115279)
-
(1994)
Journal of Affective Disorders
, vol.30
, Issue.4
, pp. 283-288
-
-
Song, C.1
-
22
-
-
29844440963
-
Etanercept and clinical outcomes, fatigue, and depression in psoriasis: Double-blind placebo-controlled randomised phase III trial
-
DOI 10.1016/S0140-6736(05)67763-X, PII S014067360567763X
-
Tyring S, Gottlieb A, Papp K, et al. Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial. Lancet 2006;367:29-35. (Pubitemid 43038667)
-
(2006)
Lancet
, vol.367
, Issue.9504
, pp. 29-35
-
-
Tyring, S.1
Gottlieb, A.2
Papp, K.3
Gordon, K.4
Leonardi, C.5
Wang, A.6
Lalla, D.7
Woolley, M.8
Jahreis, A.9
Zitnik, R.10
Cella, D.11
Krishnan, R.12
-
23
-
-
74949090006
-
The mononuclear phagocyte system and its cytokine inflammatory networks in schizophrenia and bipolar disorder
-
Drexhage RC, Knijff EM, Padmos RC, et al. The mononuclear phagocyte system and its cytokine inflammatory networks in schizophrenia and bipolar disorder. Expert Rev Neurother 2010;10:59-76.
-
(2010)
Expert Rev Neurother
, vol.10
, pp. 59-76
-
-
Drexhage, R.C.1
Knijff, E.M.2
Padmos, R.C.3
-
24
-
-
0035035367
-
The immune system, depression and the action of antidepressants
-
DOI 10.1016/S0278-5846(01)00155-5, PII S0278584601001555
-
Leonard BE. The immune system, depression and the action of antidepressants. Prog Neuropsychopharmacol Biol Psychiatry 2001;25:767-80. (Pubitemid 32374966)
-
(2001)
Progress in Neuro-Psychopharmacology and Biological Psychiatry
, vol.25
, Issue.4
, pp. 767-780
-
-
Leonard, B.E.1
-
25
-
-
37249094173
-
From inflammation to sickness and depression: When the immune system subjugates the brain
-
DOI 10.1038/nrn2297, PII NRN2297
-
Dantzer R, O'Connor JC, Freund GG, et al. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 2008;9:46-56. (Pubitemid 350295688)
-
(2008)
Nature Reviews Neuroscience
, vol.9
, Issue.1
, pp. 46-56
-
-
Dantzer, R.1
O'Connor, J.C.2
Freund, G.G.3
Johnson, R.W.4
Kelley, K.W.5
-
26
-
-
79954598830
-
Depression is an inflammatory disease, but cell-mediated immune activation is the key component of depression
-
Maes M. Depression is an inflammatory disease, but cell-mediated immune activation is the key component of depression. Prog Neuropsychopharmacol Biol Psychiatry 2011;35:664-75.
-
(2011)
Prog Neuropsychopharmacol Biol Psychiatry
, vol.35
, pp. 664-675
-
-
Maes, M.1
-
27
-
-
63449122724
-
Inflammation and its discontents: The role of cytokines in the pathophysiology of major depression
-
Miller AH, Maletic V, Raison CL. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry 2009;65:732-41.
-
(2009)
Biol Psychiatry
, vol.65
, pp. 732-741
-
-
Miller, A.H.1
Maletic, V.2
Raison, C.L.3
-
28
-
-
0033305459
-
The proinflammatory cytokine, interleukin-1α, reduces glucocorticoid receptor translocation and function
-
Pariante CM, Pearce BD, Pisell TL, et al. The proinflammatory cytokine, interleukin-1alpha, reduces glucocorticoid receptor translocation and function. Endocrinology 1999;140:4359-66. (Pubitemid 30647135)
-
(1999)
Endocrinology
, vol.140
, Issue.9
, pp. 4359-4366
-
-
Pariante, C.M.1
Pearce, B.D.2
Pisell, T.L.3
Sanchez, C.I.4
Po, C.5
Su, C.6
Miller, A.H.7
-
30
-
-
77950022119
-
CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFNalpha: Relationship to CNS immune responses and depression
-
Raison CL, Dantzer R, Kelley KW, et al. CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFNalpha: relationship to CNS immune responses and depression. Mol Psychiatry 2010;15:393-403.
-
(2010)
Mol Psychiatry
, vol.15
, pp. 393-403
-
-
Raison, C.L.1
Dantzer, R.2
Kelley, K.W.3
-
31
-
-
77954509277
-
The possible role of the kynurenine pathway in adolescent depression with melancholic features
-
Gabbay V, Klein RG, Katz Y, et al. The possible role of the kynurenine pathway in adolescent depression with melancholic features. J Child Psychol Psychiatry 2010;51:935-43.
-
(2010)
J Child Psychol Psychiatry
, vol.51
, pp. 935-943
-
-
Gabbay, V.1
Klein, R.G.2
Katz, Y.3
-
32
-
-
42049092538
-
A discriminating messenger RNA signature for bipolar disorder formed by an aberrant expression of inflammatory genes in monocytes
-
DOI 10.1001/archpsyc.65.4.395
-
Padmos RC, Hillegers MH, Knijff EM, et al. A discriminating messenger RNA signature for bipolar disorder formed by an aberrant expression of inflammatory genes in monocytes. Arch Gen Psychiatry 2008;65:395-407. (Pubitemid 351519889)
-
(2008)
Archives of General Psychiatry
, vol.65
, Issue.4
, pp. 395-407
-
-
Padmos, R.C.1
Hillegers, M.H.J.2
Knijff, E.M.3
Vonk, R.4
Bouvy, A.5
Staal, F.J.T.6
De Ridder, D.7
Kupka, R.W.8
Nolen, W.A.9
Drexhage, H.A.10
-
33
-
-
11244317215
-
The potential of minocycline for neuroprotection in human neurologic disease
-
DOI 10.1097/01.wnf.0000150867.98887.3e
-
Zemke D, Majid A. The potential of minocycline for neuroprotection in human neurologic disease. Clin Neuropharmacol 2004;27:293-8. (Pubitemid 40066232)
-
(2004)
Clinical Neuropharmacology
, vol.27
, Issue.6
, pp. 293-298
-
-
Zemke, D.1
Majid, A.2
-
34
-
-
33645662983
-
Minocycline for short-term neuroprotection
-
Elewa HF, Hilali H, Hess DC, et al. Minocycline for short-term neuroprotection. Pharmacotherapy 2006;26:515-21.
-
(2006)
Pharmacotherapy
, vol.26
, pp. 515-521
-
-
Elewa, H.F.1
Hilali, H.2
Hess, D.C.3
-
35
-
-
39149117362
-
Immunosuppression after traumatic or ischemic CNS damage: It is neuroprotective and illuminates the role of microglial cells
-
Hailer NP. Immunosuppression after traumatic or ischemic CNS damage: it is neuroprotective and illuminates the role of microglial cells. Prog Neurobiol 2008;84:211-33.
-
(2008)
Prog Neurobiol
, vol.84
, pp. 211-233
-
-
Hailer, N.P.1
-
36
-
-
44349129208
-
Does minocycline have antidepressant effect?
-
DOI 10.1016/j.biopha.2007.12.005, PII S0753332207002880
-
Pae CU, Marks DM, Han C, et al. Does minocycline have antidepressant effect? Biomed Pharmacother 2008;62:308-11. (Pubitemid 351749775)
-
(2008)
Biomedicine and Pharmacotherapy
, vol.62
, Issue.5
, pp. 308-311
-
-
Pae, C.-U.1
Marks, D.M.2
Han, C.3
Patkar, A.A.4
-
37
-
-
2442454612
-
Minocycline Up-regulates Bcl-2 and Protects against Cell Death in Mitochondria
-
DOI 10.1074/jbc.M313629200
-
Wang J, Wei Q, Wang CY, et al. Minocycline up-regulates Bcl-2 and protects against cell death in mitochondria. J Biol Chem 2004;279:19948-54. (Pubitemid 38623437)
-
(2004)
Journal of Biological Chemistry
, vol.279
, Issue.19
, pp. 19948-19954
-
-
Wang, J.1
Wei, Q.2
Wang, C.-Y.3
Hill, W.D.4
Hess, D.C.5
Dong, Z.6
-
38
-
-
0032956630
-
The mood-stabilizing agents lithium and valproate robustly increase the levels of the neuroprotective protein bcl-2 in the CNS
-
DOI 10.1046/j.1471-4159.1999.720879.x
-
Chen G, Zeng WZ, Yuan PX, et al. The mood-stabilizing agents lithium and valproate robustly increase the levels of the neuroprotective protein bcl-2 in the CNS. J Neurochem 1999;72:879-82. (Pubitemid 29055256)
-
(1999)
Journal of Neurochemistry
, vol.72
, Issue.2
, pp. 879-882
-
-
Chen, G.1
Zeng, W.-Z.2
Yuan, P.-X.3
Huang, L.-D.4
Jiang, Y.-M.5
Zhao, Z.-H.6
Manji, H.K.7
-
39
-
-
43649084022
-
Repeated unpredictable stress and antidepressants differentially regulate expression of the Bcl-2 family of apoptotic genes in rat cortical, hippocampal, and limbic brain structures
-
DOI 10.1038/sj.npp.1301527, PII 1301527
-
Kosten TA, Galloway MP, Duman RS, et al. Repeated unpredictable stress and antidepressants differentially regulate expression of the bcl-2 family of apoptotic genes in rat cortical, hippocampal, and limbic brain structures. Neuropsychopharmacology 2008;33:1545-58. (Pubitemid 351684697)
-
(2008)
Neuropsychopharmacology
, vol.33
, Issue.7
, pp. 1545-1558
-
-
Kosten, T.A.1
Galloway, M.P.2
Duman, R.S.3
Russell, D.S.4
D'Sa, C.5
-
40
-
-
37549048249
-
The BCL-2 protein family: Opposing activities that mediate cell death
-
Youle RJ, Strasser A. The BCL-2 protein family: opposing activities that mediate cell death. Nat Rev Mol Cell Biol 2008;9:47-59.
-
(2008)
Nat Rev Mol Cell Biol
, vol.9
, pp. 47-59
-
-
Youle, R.J.1
Strasser, A.2
-
41
-
-
79551681952
-
Exposure to a social stressor alters the structure of the intestinal microbiota: Implications for stressor-induced immunomodulation
-
Bailey MT, Dowd SE, Galley JD, et al. Exposure to a social stressor alters the structure of the intestinal microbiota: implications for stressor-induced immunomodulation. Brain Behav Immun 2011;25:397-407.
-
(2011)
Brain Behav Immun
, vol.25
, pp. 397-407
-
-
Bailey, M.T.1
Dowd, S.E.2
Galley, J.D.3
-
42
-
-
0035871840
-
Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia
-
Tikka T, Fiebich BL, Goldsteins G, et al. Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia. J Neurosci 2001;21:2580-8. (Pubitemid 32298200)
-
(2001)
Journal of Neuroscience
, vol.21
, Issue.8
, pp. 2580-2588
-
-
Tikka, T.1
Fiebich, B.L.2
Goldsteins, G.3
Keinanen, R.4
Koistinaho, J.5
-
43
-
-
8844261855
-
Lack of evidence of direct mitochondrial involvement in the neuroprotective effect of minocycline
-
DOI 10.1016/j.ejphar.2004.10.039, PII S0014299904012245
-
Cornet S, Spinnewyn B, Delaflotte S, et al. Lack of evidence of direct mitochondrial involvement in the neuroprotective effect of minocycline. Eur J Pharmacol 2004;505:111-19. (Pubitemid 39535682)
-
(2004)
European Journal of Pharmacology
, vol.505
, Issue.1-3
, pp. 111-119
-
-
Cornet, S.1
Spinnewyn, B.2
Delaflotte, S.3
Charnet, C.4
Roubert, V.5
Favre, C.6
Hider, H.7
Chabrier, P.E.8
Auguet, M.9
-
44
-
-
0032442475
-
Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia
-
DOI 10.1073/pnas.95.26.15769
-
Yrjanheikki J, Keinanen R, Pellikka M, et al. Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia. Proc Natl Acad Sci U S A 1998;95:15769-74. (Pubitemid 29018775)
-
(1998)
Proceedings of the National Academy of Sciences of the United States of America
, vol.95
, Issue.26
, pp. 15769-15774
-
-
Yrjanheikki, J.1
Keinanen, R.2
Pellikka, M.3
Hokfelt, T.4
Koistinaho, J.5
-
45
-
-
0034998271
-
Minocycline reduces traumatic brain injury-mediated caspase-1 activation, tissue damage, and neurological dysfunction
-
discussion 99-401
-
Sanchez Mejia RO, Ona VO, Li M, et al. Minocycline reduces traumatic brain injury-mediated caspase-1 activation, tissue damage, and neurological dysfunction. Neurosurgery 2001;48:1393-9; discussion 99-401.
-
(2001)
Neurosurgery
, vol.48
, pp. 1393-1399
-
-
Sanchez Mejia, R.O.1
Ona, V.O.2
Li, M.3
-
46
-
-
62149089881
-
Minocycline promotes dendritic spine maturation and improves behavioural performance in the fragile X mouse model
-
Bilousova TV, Dansie L, Ngo M, et al. Minocycline promotes dendritic spine maturation and improves behavioural performance in the fragile X mouse model. J Med Genet 2009;46:94-102.
-
(2009)
J Med Genet
, vol.46
, pp. 94-102
-
-
Bilousova, T.V.1
Dansie, L.2
Ngo, M.3
-
47
-
-
1542376941
-
Minocycline treatment reduces delayed oligodendrocyte death, attenuates axonal dieback, and improves functional outcome after spinal cord injury
-
DOI 10.1523/JNEUROSCI.5275-03.2004
-
Stirling DP, Khodarahmi K, Liu J, et al. Minocycline treatment reduces delayed oligodendrocyte death, attenuates axonal dieback, and improves functional outcome after spinal cord injury. J Neurosci 2004;24:2182-90. (Pubitemid 38314550)
-
(2004)
Journal of Neuroscience
, vol.24
, Issue.9
, pp. 2182-2190
-
-
Stirling, D.P.1
Khodarahmi, K.2
Liu, J.3
McPhail, L.T.4
McBride, C.B.5
Steeves, J.D.6
Ramer, M.S.7
Tetzlaff, W.8
-
48
-
-
33746635469
-
Protective effects of minocycline on 3,4-methylenedioxymethamphetamine- induced neurotoxicity in serotonergic and dopaminergic neurons of mouse brain
-
DOI 10.1016/j.ejphar.2006.05.047, PII S0014299906005413
-
Zhang L, Shirayama Y, Shimizu E, et al. Protective effects of minocycline on 3,4-methylenedioxymethamphetamine-induced neurotoxicity in serotonergic and dopaminergic neurons of mouse brain. Eur J Pharmacol 2006;544:1-9. (Pubitemid 44148565)
-
(2006)
European Journal of Pharmacology
, vol.544
, Issue.1-3
, pp. 1-9
-
-
Zhang, L.1
Shirayama, Y.2
Shimizu, E.3
Iyo, M.4
Hashimoto, K.5
-
49
-
-
0026643124
-
Tetracyclines suppress matrix metalloproteinase activity in adjuvant arthritis and in combination with flurbiprofen, ameliorate bone damage
-
Greenwald RA, Moak SA, Ramamurthy NS, et al. Tetracyclines suppress matrix metalloproteinase activity in adjuvant arthritis and in combination with flurbiprofen, ameliorate bone damage. J Rheumatol 1992;19:927-38.
-
(1992)
J Rheumatol
, vol.19
, pp. 927-938
-
-
Greenwald, R.A.1
Moak, S.A.2
Ramamurthy, N.S.3
-
50
-
-
0036260089
-
Targeting leukocyte MMPs and transmigration minocycline as a potential therapy for multiple sclerosis
-
Brundula V, Rewcastle NB, Metz LM, et al. Targeting leukocyte MMPs and transmigration: minocycline as a potential therapy for multiple sclerosis. Brain 2002;125:1297-308. (Pubitemid 34587139)
-
(2002)
Brain
, vol.125
, Issue.6
, pp. 1297-1308
-
-
Brundula, V.1
Rewcastle, N.B.2
Metz, L.M.3
Bernard, C.C.4
Yong, V.W.5
-
51
-
-
0037007645
-
Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice
-
DOI 10.1038/417074a
-
Zhu S, Stavrovskaya IG, Drozda M, et al. Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice. Nature 2002;417:74-8. (Pubitemid 34498818)
-
(2002)
Nature
, vol.417
, Issue.6884
, pp. 74-78
-
-
Zhu, S.1
Stavrovskaya, I.G.2
Drozda, M.3
Kim, B.Y.S.4
Ona, V.5
Li, M.6
Sarang, S.7
Liu, A.S.8
Hartley, D.M.9
Wu, D.C.10
Guilans, S.11
Ferrante, R.J.12
Przedborski, S.13
Kristal, B.S.14
Friedlander, R.M.15
-
52
-
-
0041335559
-
Minocycline inhibits caspase-independent and -dependent mitochondrial cell death pathways in models of Huntington's disease
-
DOI 10.1073/pnas.1832501100
-
Wang X, Zhu S, Drozda M, et al. Minocycline inhibits caspaseindependent and-dependent mitochondrial cell death pathways in models of Huntington's disease. Proc Natl Acad Sci U S A 2003;100:10483-7. (Pubitemid 37071904)
-
(2003)
Proceedings of the National Academy of Sciences of the United States of America
, vol.100
, Issue.18
, pp. 10483-10487
-
-
Wang, X.1
Zhu, S.2
Drozda, M.3
Zhang, W.4
Stavrovskaya, I.G.5
Cattaneo, E.6
Ferrante, R.J.7
Kristal, B.S.8
Friedlander, R.M.9
-
53
-
-
8644235217
-
Neuroprotection in Huntington's disease: A 2-year study on minocycline
-
DOI 10.1097/00004850-200411000-00004
-
Bonelli RM, Hodl AK, Hofmann P, et al. Neuroprotection in Huntington's disease: a 2-year study on minocycline. Int Clin Psychopharmacol 2004;19:337-42. (Pubitemid 39506988)
-
(2004)
International Clinical Psychopharmacology
, vol.19
, Issue.6
, pp. 337-342
-
-
Bonelli, R.M.1
Hodl, A.K.2
Hofmann, P.3
Kapfhammer, H.-P.4
-
54
-
-
0034761723
-
Treatment of early seropositive rheumatoid arthritis: A two-year, double-blind comparison of minocycline and hydroxychloroquine
-
DOI 10.1002/1529-0131(2001 10)44:10<2235::AID-ART3 85>3.0.CO;2-A
-
O'Dell JR, Blakely KW, Mallek JA, et al. Treatment of early seropositive rheumatoid arthritis: a two-year, double-blind comparison of minocycline and hydroxychloroquine. Arthritis Rheum 2001;44:2235-41. (Pubitemid 32977490)
-
(2001)
Arthritis and Rheumatism
, vol.44
, Issue.10
, pp. 2235-2241
-
-
O'Dell, J.R.1
Blakely, K.W.2
Mallek, J.A.3
Eckhoff, P.J.4
Leff, R.D.5
Wees, S.J.6
Sems, K.M.7
Fernandez, A.M.8
Palmer, W.R.9
Klassen, L.W.10
Paulsen, G.A.11
Haire, C.E.12
Moore, G.F.13
-
55
-
-
34848857092
-
Minocycline treatment in acute stroke: An open-label, evaluator-blinded study
-
DOI 10.1212/01.wnl.0000277487.04281.db, PII 0000611420071002000005
-
Lampl Y, Boaz M, Gilad R, et al. Minocycline treatment in acute stroke: an open-label, evaluator-blinded study. Neurology 2007;69:1404-10. (Pubitemid 47511461)
-
(2007)
Neurology
, vol.69
, Issue.14
, pp. 1404-1410
-
-
Lampl, Y.1
Boaz, M.2
Gilad, R.3
Lorberboym, M.4
Dabby, R.5
Rapoport, A.6
Anca-Hershkowitz, M.7
Sadeh, M.8
-
56
-
-
33845621428
-
Possible antipsychotic effects of minocycline in patients with schizophrenia
-
DOI 10.1016/j.pnpbp.2006.08.013, PII S0278584606003332
-
Miyaoka T, Yasukawa R, Yasuda H, et al. Possible antipsychotic effects of minocycline in patients with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2007;31:304-7. (Pubitemid 44959270)
-
(2007)
Progress in Neuro-Psychopharmacology and Biological Psychiatry
, vol.31
, Issue.1
, pp. 304-307
-
-
Miyaoka, T.1
Yasukawa, R.2
Yasuda, H.3
Hayashida, M.4
Inagaki, T.5
Horiguchi, J.6
-
57
-
-
60849097905
-
Minocycline as adjunctive therapy for schizophrenia: An open-label study
-
Miyaoka T, Yasukawa R, Yasuda H, et al. Minocycline as adjunctive therapy for schizophrenia: an open-label study. Clin Neuropharmacol 2008;31:287-92.
-
(2008)
Clin Neuropharmacol
, vol.31
, pp. 287-292
-
-
Miyaoka, T.1
Yasukawa, R.2
Yasuda, H.3
-
58
-
-
77649112679
-
A double-blind, randomized study of minocycline for the treatment of negative and cognitive symptoms in early-phase schizophrenia
-
Levkovitz Y, Mendlovich S, Riwkes S, et al. A double-blind, randomized study of minocycline for the treatment of negative and cognitive symptoms in early-phase schizophrenia. J Clin Psychiatry 2010;71:138-49.
-
(2010)
J Clin Psychiatry
, vol.71
, pp. 138-149
-
-
Levkovitz, Y.1
Mendlovich, S.2
Riwkes, S.3
-
59
-
-
38749086892
-
Antidepressant-like actions of minocycline combined with several glutamate antagonists
-
DOI 10.1016/j.pnpbp.2007.09.004, PII S0278584607003338
-
Molina-Hernandez M, Tellez-Alcantara NP, Perez-Garcia J, et al. Antidepressant-like actions of minocycline combined with several glutamate antagonists. Prog Neuropsychopharmacol Biol Psychiatry 2008;32:380-6. (Pubitemid 351178956)
-
(2008)
Progress in Neuro-Psychopharmacology and Biological Psychiatry
, vol.32
, Issue.2
, pp. 380-386
-
-
Molina-Hernandez, M.1
Tellez-Alcantara, N.P.2
Perez-Garcia, J.3
Olivera-Lopez, J.I.4
Jaramillo-Jaimes, M.T.5
-
60
-
-
51549109111
-
Desipramine or glutamate antagonists synergized the antidepressant-like actions of intra-nucleus accumbens infusions of minocycline in male Wistar rats
-
Molina-Hernandez M, Tellez-Alcantara NP, Perez-Garcia J, et al. Desipramine or glutamate antagonists synergized the antidepressant-like actions of intra-nucleus accumbens infusions of minocycline in male Wistar rats. Prog Neuropsychopharmacol Biol Psychiatry 2008;32:1660-6.
-
(2008)
Prog Neuropsychopharmacol Biol Psychiatry
, vol.32
, pp. 1660-1666
-
-
Molina-Hernandez, M.1
Tellez-Alcantara, N.P.2
Perez-Garcia, J.3
-
61
-
-
65349135346
-
Lipopolysaccharideinduced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice
-
O'Connor JC, Lawson MA, Andre C, et al. Lipopolysaccharideinduced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice. Mol Psychiatry 2009;14:511-22.
-
(2009)
Mol Psychiatry
, vol.14
, pp. 511-522
-
-
O'Connor, J.C.1
Lawson, M.A.2
Andre, C.3
-
63
-
-
0030795143
-
Differential suppression of thromboxane biosynthesis by indobufen and aspirin in patients with unstable angina
-
Cipollone F, Patrignani P, Greco A, et al. Differential suppression of thromboxane biosynthesis by indobufen and aspirin in patients with unstable angina. Circulation 1997;96:1109-16. (Pubitemid 27344211)
-
(1997)
Circulation
, vol.96
, Issue.4
, pp. 1109-1116
-
-
Cipollone, F.1
Patrignani, P.2
Greco, A.3
Panara, M.R.4
Padovano, R.5
Cuccurullo, F.6
Patrono, C.7
Rebuzzi, A.G.8
Liuzzo, G.9
Quaranta, G.10
Maseri, A.11
-
64
-
-
62949176283
-
The distinct roles of cyclooxygenase-1 and -2 in neuroinflammation: Implications for translational research
-
Choi SH, Aid S, Bosetti F. The distinct roles of cyclooxygenase-1 and -2 in neuroinflammation: implications for translational research. Trends Pharmacol Sci 2009;30:174-81.
-
(2009)
Trends Pharmacol Sci
, vol.30
, pp. 174-181
-
-
Choi, S.H.1
Aid, S.2
Bosetti, F.3
-
65
-
-
77957127862
-
Cyclooxygenases-1 and -2 differentially modulate leukocyte recruitment into the inflamed brain
-
Choi SH, Aid S, Choi U, et al. Cyclooxygenases-1 and -2 differentially modulate leukocyte recruitment into the inflamed brain. Pharmacogenomics J 2010;10:448-57.
-
(2010)
Pharmacogenomics J
, vol.10
, pp. 448-457
-
-
Choi, S.H.1
Aid, S.2
Choi, U.3
-
66
-
-
77953953898
-
Cyclooxygenase-1 null mice show reduced neuroinflammation in response to beta-amyloid
-
Choi SH, Bosetti F. Cyclooxygenase-1 null mice show reduced neuroinflammation in response to beta-amyloid. Aging (Albany NY) 2009;1:234-44.
-
(2009)
Aging (Albany NY)
, vol.1
, pp. 234-244
-
-
Choi, S.H.1
Bosetti, F.2
-
67
-
-
0038673579
-
Valproic acid down-regulates the conversion of arachidonic acid to eicosanoids via cyclooxygenase-1 and -2 in rat brain
-
Bosetti F, Weerasinghe GR, Rosenberger TA, et al. Valproic acid down-regulates the conversion of arachidonic acid to eicosanoids via cyclooxygenase-1 and -2 in rat brain. J Neurochem 2003;85:690-6. (Pubitemid 36531932)
-
(2003)
Journal of Neurochemistry
, vol.85
, Issue.3
, pp. 690-696
-
-
Bosetti, F.1
Weerasinghe, G.R.2
Rosenberger, T.A.3
Rapoport, S.I.4
-
68
-
-
3042831868
-
2 or lipoxygenase/cytochrome P450 pathways
-
DOI 10.1016/j.brainresbull.2004.04.005, PII S0361923004001029
-
Weerasinghe GR, Rapoport SI, Bosetti F. The effect of chronic lithium on arachidonic acid release and metabolism in rat brain does not involve secretory phospholipase A2 or lipoxygenase/cytochrome P450 pathways. Brain Res Bull 2004;63:485-9. (Pubitemid 38891858)
-
(2004)
Brain Research Bulletin
, vol.63
, Issue.6
, pp. 485-489
-
-
Weerasinghe, G.R.1
Rapoport, S.I.2
Bosetti, F.3
-
69
-
-
80053580791
-
Lamotrigine blocks NMDA receptor-initiated arachidonic acid signalling in rat brain: Implications for its efficacy in bipolar disorder
-
Ramadan E, Basselin M, Rao JS, et al. Lamotrigine blocks NMDA receptor-initiated arachidonic acid signalling in rat brain: implications for its efficacy in bipolar disorder. Int J Neuropsychopharmacol 2011:1-13.
-
(2011)
Int J Neuropsychopharmacol
, pp. 1-13
-
-
Ramadan, E.1
Basselin, M.2
Rao, J.S.3
-
70
-
-
73949141013
-
Is aspirin useful in patients on lithium? A pharmacoepidemiological study related to bipolar disorder
-
Stolk P, Souverein PC, Wilting I, et al. Is aspirin useful in patients on lithium? A pharmacoepidemiological study related to bipolar disorder. Prostaglandins Leukot Essent Fatty Acids 2010;82:9-14.
-
(2010)
Prostaglandins Leukot Essent Fatty Acids
, vol.82
, pp. 9-14
-
-
Stolk, P.1
Souverein, P.C.2
Wilting, I.3
-
71
-
-
0344119574
-
Lithium interaction with the cyclooxygenase 2 inhibitors rofecoxib and celecoxib and other nonsteroidal anti-inflammatory drugs
-
Phelan KM, Mosholder AD, Lu S. Lithium interaction with the cyclooxygenase 2 inhibitors rofecoxib and celecoxib and other nonsteroidal anti-inflammatory drugs. J Clin Psychiatry 2003;64:1328-34. (Pubitemid 37490238)
-
(2003)
Journal of Clinical Psychiatry
, vol.64
, Issue.11
, pp. 1328-1334
-
-
Phelan, K.M.1
Mosholder, A.D.2
Lu, S.3
-
72
-
-
33646708039
-
Shortened onset of action of antidepressants in major depression using acetylsalicylic acid augmentation: A pilot open-label study
-
DOI 10.1097/00004850-200607000-00005, PII 0000485020060700000005
-
Mendlewicz J, Kriwin P, Oswald P, et al. Shortened onset of action of antidepressants in major depression using acetylsalicylic acid augmentation: a pilot open-label study. Int Clin Psychopharmacol 2006;21:227-31. (Pubitemid 43740300)
-
(2006)
International Clinical Psychopharmacology
, vol.21
, Issue.4
, pp. 227-231
-
-
Mendlewicz, J.1
Kriwin, P.2
Oswald, P.3
Souery, D.4
Alboni, S.5
Brunello, N.6
-
73
-
-
0030065325
-
Is aspirin, as used for antithrombosis, an emotion-modulating agent?
-
DOI 10.1016/0022-3999(95)00524-2
-
Ketterer MW, Brymer J, Rhoads K, et al. Is aspirin, as used for antithrombosis, an emotion-modulating agent? J Psychosom Res 1996;40:53-8. (Pubitemid 26059538)
-
(1996)
Journal of Psychosomatic Research
, vol.40
, Issue.1
, pp. 53-58
-
-
Ketterer, M.W.1
Brymer, J.2
Rhoads, K.3
Kraft, P.4
Lovallo, W.R.5
-
74
-
-
40549126636
-
Celecoxib as an adjunct in the treatment of depressive or mixed episodes of bipolar disorder: A double-blind, randomized, placebo-controlled study
-
DOI 10.1002/hup.912
-
Nery FG, Monkul ES, Hatch JP, et al. Celecoxib as an adjunct in the treatment of depressive or mixed episodes of bipolar disorder: a double-blind, randomized, placebo-controlled study. Hum Psychopharmacol 2008;23:87-94. (Pubitemid 351359580)
-
(2008)
Human Psychopharmacology
, vol.23
, Issue.2
, pp. 87-94
-
-
Nery, F.G.1
Monkul, E.S.2
Hatch, J.P.3
Fonseca, M.4
Zunta-Soares, G.B.5
Frey, B.N.6
Bowden, C.L.7
Soares, J.C.8
-
75
-
-
33745617042
-
The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: Results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine
-
DOI 10.1038/sj.mp.4001805, PII 4001805
-
Muller N, Schwarz MJ, Dehning S, et al. The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine. Mol Psychiatry 2006;11:680-4. (Pubitemid 43989814)
-
(2006)
Molecular Psychiatry
, vol.11
, Issue.7
, pp. 680-684
-
-
Muller, N.1
Schwarz, M.J.2
Dehning, S.3
Douhe, A.4
Cerovecki, A.5
Goldstein-Muller, B.6
Spellmann, I.7
Hetzel, G.8
Maino, K.9
Kleindienst, N.10
Moller, H.-J.11
Arolt, V.12
Riedel, M.13
-
76
-
-
67650083320
-
Clinical trial of adjunctive celecoxib treatment in patients with major depression: A double blind and placebo controlled trial
-
Akhondzadeh S, Jafari S, Raisi F, et al. Clinical trial of adjunctive celecoxib treatment in patients with major depression: a double blind and placebo controlled trial. Depress Anxiety 2009;26:607-11.
-
(2009)
Depress Anxiety
, vol.26
, pp. 607-611
-
-
Akhondzadeh, S.1
Jafari, S.2
Raisi, F.3
-
77
-
-
0037381058
-
Bi-directional immune-brain communication: Implications for understanding stress, pain, and cognition
-
DOI 10.1016/S0889-1591(03)00032-1
-
Maier SF. Bi-directional immune-brain communication: implications for understanding stress, pain, and cognition. Brain Behav Immun 2003;17:69-85. (Pubitemid 36369416)
-
(2003)
Brain, Behavior, and Immunity
, vol.17
, Issue.2
, pp. 69-85
-
-
Maier, S.F.1
-
78
-
-
65649152524
-
Associations of depression with Creactive protein, IL-1, and IL-6: A meta-analysis
-
Howren MB, Lamkin DM, Suls J. Associations of depression with Creactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med 2009;71:171-86.
-
(2009)
Psychosom Med
, vol.71
, pp. 171-186
-
-
Howren, M.B.1
Lamkin, D.M.2
Suls, J.3
-
79
-
-
60449111282
-
Intrapituitary expression and regulation of the gp130 cytokine interleukin-6 and its implication in pituitary physiology and pathophysiology
-
Renner U, De Santana EC, Gerez J, et al. Intrapituitary expression and regulation of the gp130 cytokine interleukin-6 and its implication in pituitary physiology and pathophysiology. Ann N Y Acad Sci 2009;1153:89-97.
-
(2009)
Ann N y Acad Sci
, vol.1153
, pp. 89-97
-
-
Renner, U.1
De Santana, E.C.2
Gerez, J.3
-
81
-
-
60749108941
-
MMRM vs. LOCF: A comprehensive comparison based on simulation study and 25 NDA datasets
-
Siddiqui O, Hung HM, O'Neill R. MMRM vs. LOCF: a comprehensive comparison based on simulation study and 25 NDA datasets. J Biopharm Stat 2009;19:227-46.
-
(2009)
J Biopharm Stat
, vol.19
, pp. 227-246
-
-
Siddiqui, O.1
Hung, H.M.2
O'neill, R.3
-
82
-
-
0035103617
-
Absence of diurnal variation of C-reactive protein concentrations in healthy human subjects
-
Meier-Ewert HK, Ridker PM, Rifai N, et al. Absence of diurnal variation of C-reactive protein concentrations in healthy human subjects. Clin Chem 2001;47:426-30. (Pubitemid 32222455)
-
(2001)
Clinical Chemistry
, vol.47
, Issue.3
, pp. 426-430
-
-
Meier-Ewert, H.K.1
Ridker, P.M.2
Rifai, N.3
Price, N.4
Dinges, D.F.5
Mullington, J.M.6
-
83
-
-
20944433054
-
IL-6 and its circadian secretion in humans
-
DOI 10.1159/000084844
-
Vgontzas AN, Bixler EO, Lin HM, et al. IL-6 and its circadian secretion in humans. Neuroimmunomodulation 2005;12:131-40. (Pubitemid 40868672)
-
(2005)
NeuroImmunoModulation
, vol.12
, Issue.3
, pp. 131-140
-
-
Vgontzas, A.N.1
Bixler, E.O.2
Lin, H.-M.3
Prolo, P.4
Trakada, G.5
Chrousos, G.P.6
-
84
-
-
0034940379
-
Definitions of antidepressant treatment response, remission, nonresponse, partial response, and other relevant outcomes: A focus on treatment-resistant depression
-
Nierenberg AA, DeCecco LM. Definitions of antidepressant treatment response, remission, nonresponse, partial response, and other relevant outcomes: a focus on treatment-resistant depression. J Clin Psychiatry 2001;62(Suppl 16):5-9.
-
(2001)
J Clin Psychiatry
, vol.62
, Issue.SUPPL. 16
, pp. 5-9
-
-
Nierenberg, A.A.1
Dececco, L.M.2
-
85
-
-
69949169319
-
Meta-analysis of the placebo response in antidepressant trials
-
Rief W, Nestoriuc Y, Weiss S, et al. Meta-analysis of the placebo response in antidepressant trials. J Affect Disord 2009;118:1-8.
-
(2009)
J Affect Disord
, vol.118
, pp. 1-8
-
-
Rief, W.1
Nestoriuc, Y.2
Weiss, S.3
-
86
-
-
34648827438
-
Adjunctive antidepressant use and symptomatic recovery among bipolar depressed patients with concomitant manic symptoms: Findings from the STEP-BD
-
DOI 10.1176/appi.ajp.2007.05122032
-
Goldberg JF, Perlis RH, Ghaemi SN, et al. Adjunctive antidepressant use and symptomatic recovery among bipolar depressed patients with concomitant manic symptoms: findings from the STEP-BD. Am J Psychiatry 2007;164:1348-55. (Pubitemid 47461134)
-
(2007)
American Journal of Psychiatry
, vol.164
, Issue.9
, pp. 1348-1355
-
-
Goldberg, J.F.1
Perlis, R.H.2
Ghaemi, S.N.3
Calabrese, J.R.4
Bowden, C.L.5
Wisniewski, S.6
Miklowitz, D.J.7
Sachs, G.S.8
Thase, M.E.9
-
87
-
-
2442715084
-
Placebo-controlled phase I/II studies of minocycline in amyotrophic lateral sclerosis
-
Gordon PH, Moore DH, Gelinas DF, et al. Placebo-controlled phase I/II studies of minocycline in amyotrophic lateral sclerosis. Neurology 2004;62:1845-7. (Pubitemid 38661748)
-
(2004)
Neurology
, vol.62
, Issue.10
, pp. 1845-1847
-
-
Gordon, P.H.1
Moore, D.H.2
Gelinas, D.F.3
Qualls, C.4
Meister, M.E.5
Werner, J.6
Mendoza, M.7
Mass, J.8
Kushner, G.9
Miller, R.G.10
-
88
-
-
0037065502
-
Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients
-
Antithrombotic Trialists' Collaboration
-
Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002;324:71-86.
-
(2002)
BMJ
, vol.324
, pp. 71-86
-
-
-
90
-
-
77951909982
-
Emotion recollected in tranquility: Lessons learned from the COX-2 saga
-
Grosser T, Yu Y, Fitzgerald GA. Emotion recollected in tranquility: lessons learned from the COX-2 saga. Annu Rev Med 2010;61:17-33.
-
(2010)
Annu Rev Med
, vol.61
, pp. 17-33
-
-
Grosser, T.1
Yu, Y.2
Fitzgerald, G.A.3
-
91
-
-
4644289299
-
Platelet-active drugs: The relationships among dose, effectiveness, and side effects - The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
-
DOI 10.1378/chest.126.3-suppl.234S
-
Patrono C, Coller B, FitzGerald GA, et al. Platelet-active drugs: the relationships among dose, effectiveness, and side effects: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;126(3 Suppl):234S-64S. (Pubitemid 39297956)
-
(2004)
Chest
, vol.126
, Issue.3 SUPPL.
-
-
Patrono, C.1
Coller, B.2
FitzGerald, G.A.3
Hirsh, J.4
Roth, G.5
-
92
-
-
0032513878
-
Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial
-
DOI 10.1016/S0140-6736(98)04311-6
-
Hansson L, Zanchetti A, Carruthers SG, et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet 1998;351:1755-62. (Pubitemid 28269185)
-
(1998)
Lancet
, vol.351
, Issue.9118
, pp. 1755-1762
-
-
Hansson, L.1
Zanchetti, A.2
Carruthers, S.G.3
Dahlof, B.4
Elmfeldt, D.5
Julius, S.6
Menard, J.7
Rahn, K.H.8
Wedel, H.9
Westerling, S.10
-
93
-
-
0036562978
-
Low-dose aspirin does not interfere with the blood pressure-lowering effects of antihypertensive therapy
-
DOI 10.1097/00004872-200205000-00038
-
Zanchetti A, Hansson L, Leonetti G, et al. Low-dose aspirin does not interfere with the blood pressure-lowering effects of antihypertensive therapy. J Hypertens 2002;20:1015-22. (Pubitemid 34913684)
-
(2002)
Journal of Hypertension
, vol.20
, Issue.5
, pp. 1015-1022
-
-
Zanchetti, A.1
Hansson, L.2
Leonetti, G.3
Rahn, K.-H.4
Ruilope, L.5
Warnold, I.6
Wedel, H.7
-
94
-
-
0037027075
-
Effects of long-term treatment with angiotensin-converting-enzyme inhibitors in the presence or absence of aspirin: A systematic review
-
Teo KK, Yusuf S, Pfeffer M, et al. Effects of long-term treatment with angiotensin-converting-enzyme inhibitors in the presence or absence of aspirin: a systematic review. Lancet 2002;360:1037-43.
-
(2002)
Lancet
, vol.360
, pp. 1037-1043
-
-
Teo, K.K.1
Yusuf, S.2
Pfeffer, M.3
-
95
-
-
4544295352
-
Clinical trial registration: A statement from the International Committee of Medical Journal Editors
-
DOI 10.1056/NEJMe048225
-
De Angelis C, Drazen JM, Frizelle FA, et al. Clinical trial registration: a statement from the international Committee of medical journal Editors. N Engl J Med 2004;351:1250-1. (Pubitemid 39296312)
-
(2004)
New England Journal of Medicine
, vol.351
, Issue.12
, pp. 1250-1251
-
-
De Angelis, C.1
Drazen, J.M.2
Frizelle, F.A.3
Haug, C.4
Hoey, J.5
Horton, R.6
Kotzin, S.7
Laine, C.8
Marusic, A.9
Overbeke, A.J.P.M.10
Schroeder, T.V.11
Sox, H.C.12
Van Der Weyden, M.B.13
|